Aquestive Therapeutics Reports Topline Data From Part 1 Of EPIPHAST Trial Evaluating AQST-109 Epinephrine Oral Film; Co. Reports ‘AQST-109 was safe and well tolerated’
Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, today
